Tempus was founded in 2015 by Groupon co-founder Eric Lefkofsky. The company has not officially endorsed a plan to participate in an IPO.

Tempus provides genomic testing and data analysis with a focus on providing physicians a robust analytics tool that allows them to provide personalized cancer care for patients, though the company has indicated the scope may expand to include other conditions such as diabetes. The company has raised $620 million in Venture Capital funding from investors including Franklin Templeton, T. Rowe Price, Baillie Gifford, New Enterprise Associates, Revolution Group, Lightbank, and Revolution. Per company press releases, Tempus last raised $100 million in March 2020 at a post-money valuation of $5 billion.

Register for Details

For more details on financing and valuation for Tempus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Tempus's ticker symbol?

Tempus does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Tempus's stock price?

The stock price for Tempus will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Tempus Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/3/2022 Series G-3 $10MM raised $XXX.XX $XXX.XX
12/10/2020 Series G-2 $197.89MM raised $XXX.XX $XXX.XX
3/13/2020 Series G $97.31MM raised $XXX.XX $XXX.XX
5/30/2019 Series F $200MM raised $XXX.XX $XXX.XX
8/23/2018 Series E $111.02MM raised $XXX.XX $XXX.XX
3/30/2018 Series D $80MM raised $XXX.XX $XXX.XX
9/25/2017 Series C $70MM raised $XXX.XX $XXX.XX
4/17/2017 Series B-2 $30MM raised $XXX.XX $XXX.XX
11/22/2016 Series B-1 $10MM raised $XXX.XX $XXX.XX
6/20/2016 Series B $10MM raised $XXX.XX $XXX.XX
9/21/2015 Series A $10MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Tempus

Forge green plus iconForge green minus icon

What is Tempus funding to date?

Tempus has raised $826.22MM to date.
Forge green plus iconForge green minus icon

When was Tempus founded?

Tempus was founded in 2015.
Forge green plus iconForge green minus icon

Can you invest in Tempus?

Tempus is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Tempus share pre-IPO?

If you own Tempus pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Tempus a publicly traded company?

Tempus is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Tempus in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$3.66B
Updated on: Sep 1, 2022